Induction of Collagen I by CXCL10 in Ovarian Theca-Stroma Cells via the JNK Pathway

Front Endocrinol (Lausanne). 2022 Apr 1:13:823740. doi: 10.3389/fendo.2022.823740. eCollection 2022.

Abstract

Premature ovarian insufficiency (POI) poses a great threat to reproductive-age women. Ovarian fibrogenesis is a basic histologic feature of POI. Ovarian theca-stroma cells are responsible for ovarian fibrosis, but few studies have focused on the ovarian microenvironment. The role and mechanism of chemokines in the development of POI remain unclear. Here, we evaluated C-X-C motif chemokine ligand 10 (CXCL10) in biochemical POI patients, POI patients, and a POI mouse model. CXCL10 levels in serum and follicular fluid were higher in both bPOI and POI patients than in controls. An increased level of CXCL10 was also observed in a POI mouse model. CXCL10 concentrations in serum and follicular fluid were positively associated with follicle-stimulating hormone and negatively associated with antral follicle count. Our study for the first time found that CXCL10 induced COL1A1 and COL1A2 production, two subunits of collagen I in mouse theca-stroma cells by activating the JNK/c-Jun pathway. Inhibition of JNK and c-Jun attenuated the increases of COL1A1 and COL1A2 caused by CXCL10. Moreover, CXCL10 had no effects on hormone synthesis, proliferation, and apoptosis in human luteinized granulosa (hGL) cells. Our findings revealed a potential diagnostic value of CXCL10 in the early stage of POI and shed new insights into the biological function of CXCL10 in ovarian fibrosis.

Keywords: CXCL10; collagen; luteinized granulosa cells; ovarian theca–stroma cells; premature ovarian insufficiency.

MeSH terms

  • Animals
  • Chemokine CXCL10 / metabolism
  • Female
  • Fibrosis
  • Granulosa Cells / metabolism
  • Humans
  • MAP Kinase Signaling System*
  • Mice
  • Primary Ovarian Insufficiency*

Substances

  • CXCL10 protein, human
  • Chemokine CXCL10